IPO Listed — 16 Oct 2025
Listing Price: ₹620 (+27.84% vs ₹485)
Rubicon Research IPO Review
Rubicon Research IPO has been reviewed by 5 analysts, and the overall consensus is Strong Apply — carrying a score of 94. Out of the 5 analysts who have covered this IPO, 4 recommend subscribing while 1 advises caution or avoidance — reflecting a mixed view from the analyst community.
The issue is priced in the band of ₹461-485 per share , with a minimum application size of 30 shares (minimum investment of approximately ₹14,550 at the upper band) . Subscription ran from 09 Oct 2025 to 13 Oct 2025. Scroll down for the full analyst breakdown and analyst-wise verdicts.
Table of Contents
Recommend Subscribe
Based on 5 analyst reviews
Higher consensus indicates broader analyst agreement.
Analyst Review
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Rubicon Research IPO?
Based on analyst coverage tracked on this page, the overall verdict for Rubicon Research IPO is Strong Apply. Out of 5 analysts who have reviewed this IPO, 4 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.
What does the score of 94 mean for Rubicon Research IPO?
The score of 94 is an aggregate of all analyst ratings tracked for Rubicon Research IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.
What was the actual listing price of Rubicon Research IPO?
Rubicon Research IPO listed on October 16, 2025 at ₹620 , against the issue price of ₹485 — a gain of +27.84% (₹135 per share). View the full GMP history page for day-wise pre-listing trends.
What is the price band and lot size of Rubicon Research IPO?
Rubicon Research IPO was priced at ₹461-485 per share. The minimum lot size is 30 shares, making the minimum investment approximately ₹14,550 at the upper end of the price band. Subscription ran from 09 Oct 2025 to 13 Oct 2025.
Explore Rubicon Research IPO Further
Track every stage of this IPO:
Discussion 0
No comments yet
Be the first to share your thoughts!